Detalhe da pesquisa
1.
Pupillary response: cognitive effort for breast cancer survivors.
Support Care Cancer
; 27(3): 1121-1128, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097791
2.
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Ann Surg Oncol
; 25(10): 2948-2952, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987599
3.
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.
JAMA Oncol
; 10(2): 227-235, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991778
4.
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.
Clin Cancer Res
; 30(10): 2160-2169, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466643
5.
Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy.
Healthcare (Basel)
; 11(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36766992
6.
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
NPJ Breast Cancer
; 9(1): 10, 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878909
7.
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
J Clin Oncol
; 41(24): 4004-4013, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207300
8.
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
NPJ Breast Cancer
; 8(1): 80, 2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817765
9.
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Clin Cancer Res
; 28(2): 271-278, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716198
10.
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy.
Nat Cancer
; 2(6): 658-671, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712959
11.
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 27(14): 3896-3904, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602685
12.
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Clin Cancer Res
; 27(4): 975-982, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208340
13.
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.
Breast Cancer Res Treat
; 119(1): 111-8, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19655244
14.
Pilot Feasibility Study Examining Pupillary Response During Driving Simulation as a Measure of Cognitive Load in Breast Cancer Survivors.
Oncol Nurs Forum
; 47(2): 203-212, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078618
15.
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
Clin Cancer Res
; 24(23): 5820-5829, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061361
16.
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Breast Cancer Res
; 9(3): R35, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17537236
17.
Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
Fam Cancer
; 4(4): 279-84, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16341803
18.
Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis.
JCO Precis Oncol
; 1: 1-6, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172501
19.
Musculoskeletal adverse events associated with adjuvant aromatase inhibitors.
J Oncol
; 20102010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20871846
20.
Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
Ann Clin Lab Sci
; 40(4): 315-23, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947804